Engineering scalable iPSC-NK therapies
By Stefan Braam (Cellistic)
Duchenne gene therapy interim trial outcomes “striking”
By Catherine Eckford (European Pharmaceutical Review)
MHRA issues first UK guidance on phage therapies
By Catherine Eckford (European Pharmaceutical Review)
BioNTech and BMS partner to advance oncology deal worth over $10 billion
By Catherine Eckford (European Pharmaceutical Review)